Immunomodulation does not alter histology in resected Crohn's disease

About this item

Title

Immunomodulation does not alter histology in resected Crohn's disease

Content partner

University of Otago

Collection

Otago University Research Archive

Description

The use of immunomodulators (Azathioprine, 6-Mercaptopurine and Methotrexate) and biological agents (Infliximab and adalimumab) for the treatment of Crohn's disease (CD) has increased in the recent years with the aim of treating the inflammatory component of the disease and hoping to change the natural history of the disease. The aim of this study was to determine if the use of immunomodulators or biological agents in the 2 years prior to resection affects the histopathological characteristic...

Read more

Format

Research paper

Research format

Scholarly text / Journal article

Thesis level

Article

Date created

2009-12-01

Creator

Frizelle, F A / Ing, A / Gearry, R B / Whitehead, M / Faragher, I G / Dobbs, B

URL

https://hdl.handle.net/10523/35589

Related subjects

Adult / Anti-Inflammatory Agents - therapeutic use / Colon - pathology / Combined Modality Therapy / Crohn Disease - drug therapy / Crohn Disease - immunology / Crohn Disease - pathology / Crohn Disease - surgery / Female / Humans / Immunomodulation / Immunosuppressive Agents - therapeutic use / Male / Phenotype / Retrospective Studies

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.